News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

InVivo Therapeutics Corporation (NVIV) Appoints Steven McAllister as Interim CFO


12/16/2013 6:51:40 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

InVivo Therapeutics Holdings Corp. (NVIV) today announced the appointment of Steven McAllister as Interim Chief Financial Officer, effective December 31, 2013. He replaces Gregory Perry, who, as previously announced, will leave December 30, 2013 to join another local biotechnology company as its Chief Financial and Business Officer.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES